The expression of MET (also known as hepatocyte growth factor receptors) associated with circulating EVs and phosphorylated MET (Tyr1349) was increased in patients with stage 3 and stage 4 melanoma compare to control (Peinado et al., 2012). Here, MET is linked to melanoma.